Can Suboxone (buprenorphine/naloxone) cause a false‑positive urine drug screen for oxycodone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Suboxone Does NOT Contain Naltrexone and Should NOT Cause False-Positive Oxycodone Screens

Suboxone contains naloxone (not naltrexone), and while it should not directly cause a false-positive urine drug screen for oxycodone, you need to be aware that standard opiate immunoassays may not detect buprenorphine at all, and cross-reactivity issues exist with certain testing platforms.

Critical Clarification on Suboxone Components

First, let's correct a fundamental misconception: Suboxone contains buprenorphine plus naloxone, NOT naltrexone 1. These are completely different medications:

  • Naloxone: Short-acting opioid antagonist in Suboxone (4:1 ratio with buprenorphine), included to deter IV misuse
  • Naltrexone: Separate opioid antagonist medication used for alcohol/opioid dependence treatment

Interestingly, naltrexone itself can cause false-positive oxycodone screens through its metabolite noroxymorphone 2, but this is irrelevant to Suboxone.

Buprenorphine Detection Issues

Standard Opiate Panels Miss Buprenorphine

Standard urine opiate immunoassays detect morphine and codeine but NOT synthetic opioids like buprenorphine, oxycodone, or hydrocodone 3, 4. This means:

  • Patients on Suboxone will typically test negative on standard opiate screens
  • You need a specific buprenorphine immunoassay to detect buprenorphine use
  • The buprenorphine assay uses a 5 ng/mL cutoff and has 100% sensitivity when confirmed by LC-MS-MS 5

False-Positive Considerations

While buprenorphine itself should not cross-react with oxycodone assays, be aware of these testing pitfalls:

Opiate interference with buprenorphine assays: High opiate concentrations (≥2000 µg/L) can cause false-positive buprenorphine screens 6. This is the reverse of your question but highlights cross-reactivity issues.

Common medications causing false-positive opioid screens include fluoroquinolone antibiotics, which can cross-react with opiate immunoassays 4, 7. However, these don't specifically relate to Suboxone use.

Clinical Approach to Discordant Results

When you encounter a positive oxycodone screen in a patient prescribed Suboxone:

  1. Assume non-prescribed opioid use first - Buprenorphine does not metabolize to oxycodone
  2. Order confirmatory testing - Use LC-MS-MS or GC-MS to definitively identify the substance 4, 7
  3. Review complete medication list - Check for other medications that might cause cross-reactivity
  4. Check prescription drug monitoring program - Verify no concurrent oxycodone prescriptions
  5. Consider specimen validity - Temperature (90-100°F within 4 minutes), creatinine (>20 mg/dL), and adulterants 4, 5

Important Testing Caveats

False-negative buprenorphine results occur in 15-16% of compliant patients, particularly with low-dose patches 5, 8. In one study, 33 of 216 samples (15.3%) from patients on Suboxone had no detectable buprenorphine 5.

Immunoassay limitations: The false-positive rate for opiates (excluding oxycodone) can be as high as 34%, and confirmatory testing is essential 9.

Bottom Line

If a patient on Suboxone tests positive for oxycodone, this represents either true oxycodone use or a false-positive requiring confirmatory testing 4, 7. Suboxone (buprenorphine/naloxone) does not metabolize to oxycodone and should not cause this result. Always confirm positive immunoassay screens with chromatography-mass spectrometry before making clinical decisions that could damage the therapeutic relationship or result in treatment discontinuation 4.

Related Questions

Which substances can cause a false‑positive opioid urine screen, and what non‑opioid analgesic options are recommended for pain management?
Does naltrexone produce a positive result on a routine toxicology screen?
In a patient prescribed morphine extended-release and Percocet (oxycodone/acetaminophen), where would low‑level buprenorphine be detected?
Can Suboxone (buprenorphine/naloxone) cause a false positive test for benzodiazepines in urine?
Does ketamine produce a positive result for buprenorphine on a standard urine drug screen?
Is intravenous glutathione indicated for non‑alcoholic fatty liver disease, and what is the recommended dosing regimen?
What is the role of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) in treating addiction, including recommended protocols, safety contraindications, and efficacy?
Can ursodeoxycholic acid be administered to a patient with acute kidney injury or chronic kidney disease who has a mildly elevated total bilirubin (~2 mg/dL)?
When should lisinopril be used instead of olmesartan for hypertension, and what are the recommended dosing and monitoring considerations?
How should tranexamic acid be added to continuous bladder irrigation (CBI) solution for management of hematuria?
What is the appropriate management for a patient with a 1 mm × 1 mm laterally oriented outpouching in the cavernous segment of the right internal carotid artery (possible aneurysm), a hypoplastic right vertebral artery that supplies most flow to the posterior inferior cerebellar artery (PICA) with a diminutive mid‑to‑distal V4 segment, patent proximal intracranial arteries, and a hypoplastic anterior communicating artery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.